Seres Therapeutics, Inc. (MCRB) stock
MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.44+0.03 (+2.13%)
Close on Nov 18, 2026Market cap $14.32MP/E –Yield –
Seres Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Seres Therapeutics's price to book ratio was 0.4× on Nov 11, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 0.4× to 65.8×, with a median of 5.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −2.6 |
| 2025 | Dec 31, 2025 | 3.0× | −2.9 |
| 2024 | Dec 31, 2024 | 5.9× | −2.7 |
| 2023 | Oct 31, 2023 | 8.7× | −1.6 |
| 2022 | Dec 30, 2022 | 10.3× | +6.0 |
| 2021 | Dec 31, 2021 | 4.4× | −7.5 |
| 2020 | Dec 31, 2020 | 11.9× | −18.8 |
| 2018 | Jul 31, 2018 | 30.7× | +25.9 |
| 2017 | Dec 29, 2017 | 4.8× | +2.2 |
| 2016 | Dec 30, 2016 | 2.6× | −3.6 |
| 2015 | Dec 31, 2015 | 6.2× | – |
See a number that looks wrong?